phase readout
saveNCT05939128: A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
ACTIVE_NOT_RECRUITINGupdated 28m ago
community read0 votes
Sponsor: AstraZeneca. Phase: . Conditions: Breast Cancer
view source ↗
comments(0)
5-min edit window · permanent after that